Brief: 9 Meters Biopharma Qtrly Loss Per Share $0.05

9 Meters Biopharma

15/11/2021 13:27

Nov 15 (Reuters) - 9 Meters Biopharma Inc  NMTR.O :
    * QTRLY LOSS PER SHARE $0.05
    * QUARTER ENDING CASH OF $53.6 MILLION IS EXPECTED TO FUND
OPERATIONS INTO 2023
    * LARAZOTIDE PHASE 3 FOR CELIAC DISEASE INTERIM ANALYSIS
EXPECTED
IN Q2 2022
    * PHASE 2 VUROLENATIDE VIBRANT STUDY ENROLLMENT ANTICIPATED
TO BE
COMPLETED BEFORE YEAR-END
    * Q3 EARNINGS PER SHARE VIEW $-0.04 -- REFINITIV IBES DATA

Source text for Eikon:  ID: 
Further company coverage:  NMTR.O 

 ((Reuters.Briefs@thomsonreuters.com;))